DataString Consulting Company Logo
DataString Consulting Company Logo
Hydroxocobalamin Acetate Market
Home»Recent Reports»Hydroxocobalamin Acetate Market

Hydroxocobalamin Acetate Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1802256, Published - May 2025

Segmented in Form (Injectable, Oral, Topical), Application (Pharmaceuticals, Nutraceuticals, Cosmetics, Veterinary Medicine, Research & Development, Others), Distribution Channels, Product Type and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Hydroxocobalamin Acetate
Market Outlook

The market, for Hydroxocobalamin acetate was estimated at $468.8 million in 2024; and it is anticipated to increase to $739.8 million by 2030 with projections indicating a growth to around $1.1 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 7.9% over the forecast period. The strong Compound Annual Growth Rate (CAGR) highlights the importance of Hydroxocobalamin Acetate across different industries today. This increase is mainly due to the compounds use in various healthcare settings and the growing acknowledgment of its advantages by healthcare providers. Moreover a key factor driving its popularity is the rising prevalence of Vitamin B12 deficiency on a scale leading to the need for effective solutions such, as Hydroxocobalamin Acetate. Continuous exploration and innovation efforts continue to play a role in shaping the current market landscape for this compound due, to evolving regulatory environments and advancements in drug delivery methods.


Hydroxocobalamin Acetate is a of Vitamin B12 known mainly for its effectiveness in treating pernicious anemia and cyanide poisoning as well as addressing Vitamin B12 deficiency issues. Its usage has broadened into areas beyond its traditional applications due, to its unique physiological characteristics and stability.


Market Size Forecast & Key Insights

2019
$468M2024
2029
$1B2034

Absolute Growth Opportunity = $534M

The Hydroxocobalamin Acetate market is projected to grow from $468.8 million in 2024 to $1.00 billion in 2034. This represents a CAGR of 7.9%, reflecting rising demand across Cyanide Poisoning Treatment, Pernicious Anemia Treatment and Vitamin B12 Deficiency Management.

The Hydroxocobalamin Acetate market is set to add $534 million between 2024 and 2034, with manufacturer targeting Nutraceuticals & Cosmetics Application projected to gain a larger market share.

With Increasing demand for vitamin b12 therapies, and Advancements in pharmaceutical technology, Hydroxocobalamin Acetate market to expand 114% between 2024 and 2034.

Opportunities in the Hydroxocobalamin Acetate Market

Strategic Collaborations for Production Advancement

With the growing utilization of Hydroxocobalamin acetate, in addressing health issues comes the opportunity for profitable partnerships to enhance manufacturing methods significantly noticeable. Working together can boost effective production processes to meet the rising worldwide need.

Expanding Applications in Neurology and Technological Innovations in Drug Delivery Methods

Hydroxocobalamin acetates broad range of benefits is especially valuable in treating neurological conditions like Alzheimers and Multiple Sclerosis and shows promising growth potential ahead of us. With the projected increase in the population worldwide being diagnosed with neurological disorders on the rise there seems ample room for growth, in utilizing Hydroxocobalamin acetate in such cases.

Leverage the increasing use of state of the art drug delivery techniques by exploring the potential of hydroxocobalamin acetate with delivery systems such, as nanotechnology and liposome carriers to enhance targeted treatments significantly and open up a new market opportunity.

Growth Opportunities in North America and Europe

Europe Outlook

In Europe – well known for its regulations and cutting edge pharmaceutical sector – Hydroxocobalamin Acetate finds significant demand and opportunities for growth due to its application in treating vitamin B12 deficiency within the regions focus on top notch pharmaceuticals market. The competition is fierce among leading chemical companies in Europe as they strive to claim a larger share of the Hydroxocobalamin Acetate market driven by the increasing prevalence of vitamin B12 deficiency, among vegan and elderly populations. Additionally‌‌‌, the focus on promoting healthcare in Europe is driving the need, for Hydroxocobalamin Acetate.

North America Outlook

North America has always been a market for Hydroxocobalamin Acetate due to its strong pharmaceutical industry presence. The ongoing progress in healthcare technology and the rising investment in research and development in the region provide chances for Hydroxocobalamin Acetate manufacturers. The existence of players and increasing competition, in the United States drives innovation and enhances the quality of Hydroxocobalamin Acetate production. One significant factor fueli​ng the growth of the market is the rising awareness of healthcare and the use of supplements that include Hydroxocobalamin Acetate. This trend is particularly noticeable among adults in the region and is playing a crucial role, in driving market expansion.

North America Outlook

North America has always been a market for Hydroxocobalamin Acetate due to its strong pharmaceutical industry presence. The ongoing progress in healthcare technology and the rising investment in research and development in the region provide chances for Hydroxocobalamin Acetate manufacturers. The existence of players and increasing competition, in the United States drives innovation and enhances the quality of Hydroxocobalamin Acetate production. One significant factor fueli​ng the growth of the market is the rising awareness of healthcare and the use of supplements that include Hydroxocobalamin Acetate. This trend is particularly noticeable among adults in the region and is playing a crucial role, in driving market expansion.

Europe Outlook

In Europe – well known for its regulations and cutting edge pharmaceutical sector – Hydroxocobalamin Acetate finds significant demand and opportunities for growth due to its application in treating vitamin B12 deficiency within the regions focus on top notch pharmaceuticals market. The competition is fierce among leading chemical companies in Europe as they strive to claim a larger share of the Hydroxocobalamin Acetate market driven by the increasing prevalence of vitamin B12 deficiency, among vegan and elderly populations. Additionally‌‌‌, the focus on promoting healthcare in Europe is driving the need, for Hydroxocobalamin Acetate.

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : U.S., Germany, Japan, China, India are expected to grow at 5.1% to 7.6% CAGR

2

Emerging Markets : Mexico, Brazil, South Africa are expected to grow at 9.1% to 10.9% CAGR

Market Analysis Chart

The Hydroxocobalamin Acetate market is influenced by a mix of factors with a focus on the growing awareness and appreciation for this biologically active version of vitamin B12 in medical applications such as supporting red blood cell production and neurological health functions has been widely accepted due to the rise, in health conscious individuals worldwide. Nevertheless the market faces hurdles predominantly related to the production costs and strict regulatory measures in place.

Recent Developments and Technological Advancement

December 2024

Pfizer introduced a series of Hydroxocobalamine Acetate injections to their product range in order to enhance their market foothold and broaden their portfolio.

November 2024

Merck opened a facility dedicated to producing and distributing Hydroxocobalamin Acetate to meet the increasing worldwide demand, for healthcare solutions.

October 2024

Gilead Sciences and Roche joined forces to explore the use of Hydroxycobalamin Acetate in addressing conditions. They pooled their knowledge, in research and development for the project.

Hydroxocobalamin Acetate is an used pharmaceutical compound for treating Vitamin B12 deficiency and has garnered significant attention in the market lately due to ongoing advancements in the pharmaceutical sector that have increased the need for effective medications, like Hydroxocobalamin Acetate.

Impact of Industry Transitions on the Hydroxocobalamin Acetate Market

As a core segment of the Pharmaceutical industry, the Hydroxocobalamin Acetate market develops in line with broader industry shifts. Over recent years, transitions such as Shifting Pharmaceutical Trends and Emergence in Cosmetic Industry have redefined priorities across the Pharmaceutical sector, influencing how the Hydroxocobalamin Acetate market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Shifting Pharmaceutical Trends:

In the pharmaceutical industry there have been changes in how Hydroxocobalamin Acetate is being utilized and valued over time. This substance is mainly recognized for its effectiveness in treating Vitamin B12 deficiency. However in times it has also been applied in other medical fields such as detoxifying cyanide during critical medical situations. This shift not only raised the need for Hydroxocobalamin Acetate but also expanded its reach in the market resulted in heightened research and a possible rise, in more sophisticated formulations.

2

Emergence in Cosmetic Industry:

The cosmetic industry has seen a shift with the inclusion of Hydroxocobalamin Acetate in skincare products gaining popularity for its antioxidant benefits and ability to revitalize and repair skin cells. This emerging trend meets the increasing need for skincare solutions that deliver results and opens up possibilities, for utilizing Hydroxocobalamin Acetate in innovative ways.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Pharmaceutical industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Pharmaceutical industry cascade into the Hydroxocobalamin Acetate market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Increasing Demand for Vitamin B12 Therapies, and Rising Acceptance of Vegan and Vegetarian Food Habits

Doctors and medical professionals worldwide are also prescribing Hydroxocobalamin Acetate frequently now as a powerful of Vitamin B12 to address ailments such as vitamin B12 deficiency and neurological disorders as well as cyanide poisoning cases too. With the rise in health problems among the population surging up the need for effective treatments is also boosting the market demand, for Hydroxocobalamin Acetate significantly.
The growing worldwide focus on animal welfare and health has also inspired individuals to embrace vegan and vegetarian diets frequently these days. However a common issue with these choices is also the lack of essential nutrients such as Vitamin B12 that are also usually present in animal derived foods. As a solution to address this shortfall in nutrients people have also been turning to supplements like Hydroxocobalamin Acetate often lately which has also led to a rise in its popularity and demand, in the market.
Groundbreaking progress in technology such as nanotechnology and innovative drug delivery methods have also paved the way for enhancing the effectiveness and availability of Hydroxocobalamin Acetate medication. Ongoing research is also focused intensively to refine dosage forms of the product with a view, to driving market expansion in the future.

Restraint: Stringent Regulatory Framework

Hydroxocobalamin Acetate is a man made of Vitamin B12 that has medical uses and is subject to strict regulations in different countries worldwide. The rigorous rules and approval procedures associated with Hydroxocobalamin Acetate production often lead to delays in its manufacturing and distribution processes. Major industry players are required to maneuver through these protocols with significant investments of time and resources at stake which ultimately have a direct influence, on market demand and trends.

Challenge: High Production Costs

The process of creating Hydroxocobalamin Acetate requires various stages and specific tools along with experienced workers involved in the process that leads to expensive production costs which may discourage market entry significantly due to higher prices of final products resulting from these increased production expenses and could limit market reach particularly in regions with weaker buying power thereby impacting the overall demand, for Hydroxocobalamin Acetate indirectly.

Supply Chain Landscape

Raw Material Suppliers

Sigma-Aldrich

Evonik Industries

Intermediates Production

Pfizer Inc.

Sanofi S.A

API Manufacturing
Merck KGaA / GlaxoSmithKline plc
End Users
Healthcare / Pharmaceuticals / Clinical Laboratories
Raw Material Suppliers

Sigma-Aldrich

Evonik Industries

Intermediates Production

Pfizer Inc.

Sanofi S.A

API Manufacturing

Merck KGaA

GlaxoSmithKline plc

End Users

Healthcare

Pharmaceuticals

Clinical Laboratories

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Cyanide Poisoning Treatment
Pharmaceutical
Merck KGaA
Focus on advanced drug delivery methods and innovative production techniques, while ensuring the highest safety standards
Vitamin B12 Deficiency Treatment
Healthcare
Cayman Chemical
Develop customized formulations to cater to individual patient needs. Collaborate with leading healthcare providers to increase market penetration
Diagnostic Industry
Medical
Santa Cruz Biotechnology
Invest in rigorous R&D activities to innovate and enhance product utility. Formulate robust marketing strategies to drive product adoption and market share

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Hydroxocobalamin Acetate market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Hydroxocobalamin Acetate in Pernicious Anemia Treatment, Vitamin B12 Deficiency Management and Cyanide Poisoning Treatment

Pernicious Anemia Treatment

Hydroxocobalamin Acetate is widely used to treat pernicious anemia. A condition that arises when the body struggles to produce sufficient healthy red blood cells due to a deficiency, in vitamin B12 levels. The injectable version of Hydroxocobalamin Acetate serves a function in addressing pernicious anemia by being quickly absorbed and remaining active in the body for an extended period afterward.

Vitamin B12 Deficiency Management

Hydroxoclucobalamin Acetate plays a role in addressing Vitamin B12 deficiency by aiding in the production of myelin essential for optimal nervous system function. There is an advantage to its higher retention rate in the body compared to others of Vitamin B12. This attribute is utilized by leading nutritional supplement companies to enhance their product range and solidify their presence, in the market.

Cyanide Poisoning Treatment

Hydroxocobalamin Acetate is commonly used to treat cyanide poisoning due to its capacity to interact with cyanide and create cyanocobalamin, which is a key component in numerous lifesaving antidotes globally. The treatments effectiveness is further enhanced by the products bioavailability and its capability to attach to cyanide ions. The pharmaceutical industry leaders play a role, in the market for these treatments by leveraging their advanced manufacturing capabilities and strong market presence.

Hydroxocobalamin Acetate vs. Substitutes:
Performance and Positioning Analysis

Hydroxocobalamin Acetate distinguishes itself from alternatives such as Cyanocobalamin due to its superior retention and fewer side effects. It presents a market growth potential owing to increasing vitamin B12 deficiency cases worldwide

Hydroxocobalamin Acetate
  • Methylcobalamin /
  • Cyanocobalamin /
  • Adenosylcobalamin
    Efficient treatment for cyanide poisoning, plays a crucial role in the normal functioning of the brain and nervous system
    Limited availability, potential side effects like nausea and headaches
    Extremely effective in treating Vitamin B12 deficiency, readily available in several forms like tablets, oils, and injections
    Possibility of side effects including allergic reactions

Hydroxocobalamin Acetate vs. Substitutes:
Performance and Positioning Analysis

Hydroxocobalamin Acetate

  • Efficient treatment for cyanide poisoning, plays a crucial role in the normal functioning of the brain and nervous system
  • Limited availability, potential side effects like nausea and headaches

Methylcobalamin / Cyanocobalamin / Adenosylcobalamin

  • Extremely effective in treating Vitamin B12 deficiency, readily available in several forms like tablets, oils, and injections
  • Possibility of side effects including allergic reactions

Hydroxocobalamin Acetate distinguishes itself from alternatives such as Cyanocobalamin due to its superior retention and fewer side effects. It presents a market growth potential owing to increasing vitamin B12 deficiency cases worldwide

Loading...

Research Methodology

This market research methodology defines the Hydroxocobalamin Acetate market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Pharmaceutical ecosystem, we analyze Hydroxocobalamin Acetate across Pharmaceuticals, Nutraceuticals, and Cosmetics Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as BASF SE, Pfizer Inc., and Sanofi S.A. by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Suppliers, Intermediates Production, and API Manufacturing. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Pharmaceutical revenues to estimate the Hydroxocobalamin Acetate segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Suppliers (Sigma-Aldrich, Evonik Industries), Intermediates Production (Pfizer Inc., Sanofi S.A), and API Manufacturing. Our parallel substitute analysis examines Methylcobalamin, Cyanocobalamin, and Adenosylcobalamin, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as BASF SE, Pfizer Inc., and Sanofi S.A., analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Hydroxocobalamin Acetate market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Hydroxocobalamin Acetate Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 505 million
Revenue Forecast in 2034USD 1.00 billion
Growth RateCAGR of 7.9% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 2024468 million
Growth OpportunityUSD 534 million
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD million and Industry Statistics
Market Size 2024468 million USD
Market Size 2027588 million USD
Market Size 2029685 million USD
Market Size 2030739 million USD
Market Size 20341.00 billion USD
Market Size 20351.08 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredForm, Application, Distribution Channels, Product Type
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledBASF SE, Pfizer Inc., Sanofi S.A., Merck KGaA, Bayer AG, Daiichi Sankyo Co. Ltd, Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Sun Pharmaceutical Industries Ltd., Novartis International AG and Johnson & Johnson Services Inc.
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Hydroxocobalamin Acetate Market Size, Opportunities & Strategic Insights, by Form

4.1Injectable
4.2Oral
4.3Topical
Chapter 5

Hydroxocobalamin Acetate Market Size, Opportunities & Strategic Insights, by Application

5.1Pharmaceuticals
5.2Nutraceuticals
5.3Cosmetics
5.4Veterinary Medicine
5.5Research & Development
5.6Others
Chapter 6

Hydroxocobalamin Acetate Market Size, Opportunities & Strategic Insights, by Distribution Channels

6.1Hospital Pharmacies
6.2Retail Pharmacies
6.3Online Pharmacies
6.4Direct Sales
Chapter 7

Hydroxocobalamin Acetate Market Size, Opportunities & Strategic Insights, by Product Type

7.1Prescription Based
7.2Over-the-counter
Chapter 8

Hydroxocobalamin Acetate Market, by Region

8.1North America Hydroxocobalamin Acetate Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Hydroxocobalamin Acetate Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Hydroxocobalamin Acetate Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Hydroxocobalamin Acetate Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Hydroxocobalamin Acetate Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Hydroxocobalamin Acetate Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1BASF SE
9.2.2Pfizer Inc.
9.2.3Sanofi S.A.
9.2.4Merck KGaA
9.2.5Bayer AG
9.2.6Daiichi Sankyo Co. Ltd
9.2.7Dr. Reddy's Laboratories Ltd.
9.2.8Teva Pharmaceutical Industries Ltd.
9.2.9GlaxoSmithKline plc.
9.2.10Sun Pharmaceutical Industries Ltd.
9.2.11Novartis International AG
9.2.12Johnson & Johnson Services Inc.